Next-Generation Technologies and Strategies for the Management of Retinoblastoma
Abstract
:1. Introduction
2. Retinoblastoma
3. Retinoblastoma Therapy
4. Molecular Testing in Retinoblastoma
5. Retinoblastoma Genetics and Genomics
6. eyeGENE®
7. Modern Day Genetics and Prognostics for Retinoblastoma
8. Patents
Author Contributions
Funding
Conflicts of Interest
References
- Astuti, G.D.N.; van den Born, L.I.; Khan, M.I.; Hamel, C.P.; Bocquet, B.; Manes, G.; Quinodoz, M.; Ali, M.; Toomes, C.; McKibbin, M.; et al. Identification of Inherited Retinal Disease-Associated Genetic Variants in 11 Candidate Genes. Genes 2018, 9, 21. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Daiger, S.P.; Rossiter, B.R.; Greenberg, J.; Christoffels, A.; Hide, W. Data services and software for identifying genes and mutations causing retinal degeneration. Investig. Ophthalmol. Vis. Sci. 1998, 39, S295. [Google Scholar]
- Roberts, L.; Ratnapriya, R.; du Plessis, M.; Chaitankar, V.; Ramesar, R.S.; Swaroop, A. Molecular Diagnosis of Inherited Retinal Diseases in Indigenous African Populations by Whole-Exome Sequencing. Investig. Ophthalmol. Vis. Sci. 2016, 57, 6374–6381. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fiorentino, A.; Yu, J.; Arno, G.; Pontikos, N.; Halford, S.; Broadgate, S.; Michaelides, M.; Carss, K.J.; Raymond, F.L.; Cheetham, M.E.; et al. Novel homozygous splicing mutations in ARL2BP cause autosomal recessive retinitis pigmentosa. Mol. Vis. 2018, 24, 603–612. [Google Scholar]
- Abu Diab, A.; AlTalbishi, A.; Rosin, B.; Kanaan, M.; Kamal, L.; Swaroop, A.; Chowers, I.; Banin, E.; Sharon, D.; Khateb, S. The combination of whole-exome sequencing and clinical analysis allows better diagnosis of rare syndromic retinal dystrophies. Acta Ophthalmol. 2019, 97, e877–e886. [Google Scholar] [CrossRef]
- Daiger, S.P.; Sullivan, L.S.; Bowne, S.J.; Birch, D.G.; Heckenlively, J.R.; Pierce, E.A.; Weinstock, G.M. Targeted high-throughput DNA sequencing for gene discovery in retinitis pigmentosa. Adv. Exp. Med. Biol. 2010, 664, 325–331. [Google Scholar] [CrossRef] [Green Version]
- Zenteno, J.C.; Garcia-Montano, L.A.; Cruz-Aguilar, M.; Ronquillo, J.; Rodas-Serrano, A.; Aguilar-Castul, L.; Matsui, R.; Vencedor-Meraz, C.I.; Arce-Gonzalez, R.; Graue-Wiechers, F.; et al. Extensive genic and allelic heterogeneity underlying inherited retinal dystrophies in Mexican patients molecularly analyzed by next-generation sequencing. Mol. Genet. Genomic Med. 2019. [Google Scholar] [CrossRef]
- Soliman, S.E.; Racher, H.; Zhang, C.; MacDonald, H.; Gallie, B.L. Genetics and Molecular Diagnostics in Retinoblastoma—An Update. Asia Pac. J. Ophthalmol. (Phila) 2017, 6, 197–207. [Google Scholar] [CrossRef]
- Dimaras, H.; Kimani, K.; Dimba, E.A.; Gronsdahl, P.; White, A.; Chan, H.S.; Gallie, B.L. Retinoblastoma. Lancet 2012, 379, 1436–1446. [Google Scholar] [CrossRef] [Green Version]
- Draper, G.J.; Sanders, B.M.; Brownbill, P.A.; Hawkins, M.M. Patterns of risk of hereditary retinoblastoma and applications to genetic counselling. Br. J. Cancer 1992, 66, 211–219. [Google Scholar] [CrossRef] [Green Version]
- MacCarthy, A.; Birch, J.M.; Draper, G.J.; Hungerford, J.L.; Kingston, J.E.; Kroll, M.E.; Onadim, Z.; Stiller, C.A.; Vincent, T.J.; Murphy, M.F.G. Retinoblastoma in Great Britain 1963–2002. Br. J. Ophthalmol. 2009, 93, 33. [Google Scholar] [CrossRef] [PubMed]
- Munier, F.L.; Beck-Popovic, M.; Chantada, G.L.; Cobrinik, D.; Kivela, T.T.; Lohmann, D.; Maeder, P.; Moll, A.C.; Carcaboso, A.M.; Moulin, A.; et al. Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. “Alive, with good vision and no comorbidity”. Prog. Retin. Eye Res. 2019, 73, 100764. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kamihara, J.; Bourdeaut, F.; Foulkes, W.D.; Molenaar, J.J.; Mosse, Y.P.; Nakagawara, A.; Parareda, A.; Scollon, S.R.; Schneider, K.W.; Skalet, A.H.; et al. Retinoblastoma and Neuroblastoma Predisposition and Surveillance. Clin. Cancer Res. 2017, 23, e98–e106. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lin, P.; O’Brien, J.M. Frontiers in the management of retinoblastoma. Am. J. Ophthalmol. 2009, 148, 192–198. [Google Scholar] [CrossRef] [PubMed]
- Friend, S.H.; Bernards, R.; Rogelj, S.; Weinberg, R.A.; Rapaport, J.M.; Albert, D.M.; Dryja, T.P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986, 323, 643–646. [Google Scholar] [CrossRef] [PubMed]
- Lee, W.H.; Bookstein, R.; Hong, F.; Young, L.J.; Shew, J.Y.; Lee, E.Y. Human retinoblastoma susceptibility gene: Cloning, identification, and sequence. Science 1987, 235, 1394–1399. [Google Scholar] [CrossRef] [Green Version]
- Fung, Y.K.; Murphree, A.L.; T’Ang, A.; Qian, J.; Hinrichs, S.H.; Benedict, W.F. Structural evidence for the authenticity of the human retinoblastoma gene. Science 1987, 236, 1657–1661. [Google Scholar] [CrossRef]
- Chantada, G.L.; Qaddoumi, I.; Canturk, S.; Khetan, V.; Ma, Z.; Kimani, K.; Yeniad, B.; Sultan, I.; Sitorus, R.S.; Tacyildiz, N.; et al. Strategies to manage retinoblastoma in developing countries. Pediatr. Blood Cancer 2011, 56, 341–348. [Google Scholar] [CrossRef]
- Little, M.P.; Kleinerman, R.A.; Stiller, C.A.; Li, G.; Kroll, M.E.; Murphy, M.F. Analysis of retinoblastoma age incidence data using a fully stochastic cancer model. Int. J. Cancer 2012, 130, 631–640. [Google Scholar] [CrossRef] [Green Version]
- Fernandes, A.G.; Pollock, B.D.; Rabito, F.A. Retinoblastoma in the United States: A 40-Year Incidence and Survival Analysis. J. Pediatr. Ophthalmol. Strabismus 2018, 55, 182–188. [Google Scholar] [CrossRef] [Green Version]
- Jain, M.; Rojanaporn, D.; Chawla, B.; Sundar, G.; Gopal, L.; Khetan, V. Retinoblastoma in Asia. Eye (Lond) 2019, 33, 87–96. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- da Rocha-Bastos, R.; Araujo, J.; Silva, R.; Gil-da-Costa, M.; Brandao, E.; Farinha, N.; Falcao-Reis, F.; Dinah-Braganca, T. Retinoblastoma: Experience of a referral center in the North Region of Portugal. Clin. Ophthalmol. 2014, 8, 993–997. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Berry, J.L.; Lewis, L.; Zolfaghari, E.; Green, S.; Le, B.H.A.; Lee, T.C.; Murphree, A.L.; Kim, J.W.; Jubran, R. Lack of correlation between age at diagnosis and RB1 mutations for unilateral retinoblastoma: The importance of genetic testing. Ophthalmic Genet. 2018, 39, 407–409. [Google Scholar] [CrossRef] [PubMed]
- Kaliki, S.; Srinivasan, V.; Gupta, A.; Mishra, D.K.; Naik, M.N. Clinical features predictive of high-risk retinoblastoma in 403 Asian Indian patients: A case-control study. Ophthalmology 2015, 122, 1165–1172. [Google Scholar] [CrossRef]
- Linn Murphree, A. Intraocular retinoblastoma: The case for a new group classification. Ophthalmol. Clin. N. Am. 2005, 18, 41–53. [Google Scholar] [CrossRef]
- Mallipatna, A.C.; Gallie, B.L.; Chévez-Barrios, P.; Lumbroso-Le Rouic, L.; Chantada, G.L.; Brisse, H.J.; Doz, F.; Munier, F.L.; Albert, D.M.; Català-Mora, J.; et al. Retinoblastoma. In AJCC Cancer Staging Manual, 8th ed.; Edge, S., Greene, F., Byrd, D.R., Brookland, R.K., Washington, M.K., Gershenwald, J.E., Compton, C.C., Hess, K.R., Sullivan, D.C., Jessup, J.M., et al., Eds.; Springer International Publishing: New York, NY, USA, 2017; pp. 819–831. [Google Scholar]
- Shields, C.L.; Mashayekhi, A.; Au, A.K.; Czyz, C.; Leahey, A.; Meadows, A.T.; Shields, J.A. The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology 2006, 113, 2276–2280. [Google Scholar] [CrossRef]
- Francis, J.H.; Levin, A.M.; Zabor, E.C.; Gobin, Y.P.; Abramson, D.H. Ten-year experience with ophthalmic artery chemosurgery: Ocular and recurrence-free survival. PLoS ONE 2018, 13, e0197081. [Google Scholar] [CrossRef]
- Berry, J.L.; Jubran, R.; Kim, J.W.; Wong, K.; Bababeygy, S.R.; Almarzouki, H.; Lee, T.C.; Murphree, A.L. Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage. Pediatr. Blood Cancer 2013, 60, 688–693. [Google Scholar] [CrossRef]
- Soliman, S.E.; VandenHoven, C.; MacKeen, L.D.; Heon, E.; Gallie, B.L. Optical Coherence Tomography-Guided Decisions in Retinoblastoma Management. Ophthalmology 2017, 124, 859–872. [Google Scholar] [CrossRef]
- Berry, J.L.; Cobrinik, D.; Kim, J.W. Detection and Intraretinal Localization of an ‘Invisible’ Retinoblastoma Using Optical Coherence Tomography. Ocul. Oncol. Pathol. 2016, 2, 148–152. [Google Scholar] [CrossRef] [Green Version]
- Skalet, A.H.; Gombos, D.S.; Gallie, B.L.; Kim, J.W.; Shields, C.L.; Marr, B.P.; Plon, S.E.; Chevez-Barrios, P. Screening Children at Risk for Retinoblastoma: Consensus Report from the American Association of Ophthalmic Oncologists and Pathologists. Ophthalmology 2018, 125, 453–458. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Foster, A.; Boyes, L.; Burgess, L.; Carless, S.; Bowyer, V.; Jenkinson, H.; Parulekar, M.; Ainsworth, J.; Hungerford, J.; Onadim, Z.; et al. Patient understanding of genetic information influences reproductive decision making in retinoblastoma. Clin. Genet. 2017, 92, 587–593. [Google Scholar] [CrossRef] [PubMed]
- Imbert-Bouteille, M.; Gauthier-Villars, M.; Leroux, D.; Meunier, I.; Aerts, I.; Lumbroso-Le Rouic, L.; Lejeune, S.; Delnatte, C.; Abadie, C.; Pujol, P.; et al. Osteosarcoma without prior retinoblastoma related to RB1 low-penetrance germline pathogenic variants: A novel type of RB1-related hereditary predisposition syndrome? Mol. Genet. Genomic Med. 2019, e913. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Frenkel, S.; Zloto, O.; Sagi, M.; Fraenkel, A.; Pe’er, J. Genotype-phenotype correlation in the presentation of retinoblastoma among 149 patients. Exp Eye Res. 2016, 146, 313–317. [Google Scholar] [CrossRef]
- Lohmann, D.R.; Gallie, B.L. Retinoblastoma. In GeneReviews((R)); Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Stephens, K., Amemiya, A., Eds.; University of Washington, 1993. [Google Scholar]
- Grotta, S.; D’Elia, G.; Scavelli, R.; Genovese, S.; Surace, C.; Sirleto, P.; Cozza, R.; Romanzo, A.; De Ioris, M.A.; Valente, P.; et al. Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma. BMC Cancer 2015, 15, 841. [Google Scholar] [CrossRef] [Green Version]
- Devarajan, B.; Prakash, L.; Kannan, T.R.; Abraham, A.A.; Kim, U.; Muthukkaruppan, V.; Vanniarajan, A. Targeted next generation sequencing of RB1 gene for the molecular diagnosis of Retinoblastoma. BMC Cancer 2015, 15, 320. [Google Scholar] [CrossRef] [Green Version]
- Jiang, Y.L.; Zhao, Z.Y.; Li, B.R.; Wang, H.; Yu, E.D.; Ning, S.B. STK11 gene analysis reveals a significant number of splice mutations in Chinese PJS patients. Cancer Genet. 2019, 230, 47–57. [Google Scholar] [CrossRef] [Green Version]
- Rushlow, D.; Piovesan, B.; Zhang, K.; Prigoda-Lee, N.L.; Marchong, M.N.; Clark, R.D.; Gallie, B.L. Detection of mosaic RB1 mutations in families with retinoblastoma. Hum. Mutat. 2009, 30, 842–851. [Google Scholar] [CrossRef]
- Chen, Z.; Moran, K.; Richards-Yutz, J.; Toorens, E.; Gerhart, D.; Ganguly, T.; Shields, C.L.; Ganguly, A. Enhanced sensitivity for detection of low-level germline mosaic RB1 mutations in sporadic retinoblastoma cases using deep semiconductor sequencing. Hum. Mutat. 2014, 35, 384–391. [Google Scholar] [CrossRef] [Green Version]
- Sachdeva, U.M.; O’Brien, J.M. Understanding pRb: Toward the necessary development of targeted treatments for retinoblastoma. J. Clin. Investig. 2012, 122, 425–434. [Google Scholar] [CrossRef] [Green Version]
- Dimaras, H.; Corson, T.W.; Cobrinik, D.; White, A.; Zhao, J.; Munier, F.L.; Abramson, D.H.; Shields, C.L.; Chantada, G.L.; Njuguna, F.; et al. Retinoblastoma. Nat. Rev. Dis. Primers 2015, 1, 15021. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rodriguez-Galindo, C.; Orbach, D.B.; VanderVeen, D. Retinoblastoma. Pediatr. Clin. N. Am. 2015, 62, 201–223. [Google Scholar] [CrossRef] [PubMed]
- Dommering, C.J.; Mol, B.M.; Moll, A.C.; Burton, M.; Cloos, J.; Dorsman, J.C.; Meijers-Heijboer, H.; van der Hout, A.H. RB1 mutation spectrum in a comprehensive nationwide cohort of retinoblastoma patients. J. Med. Genet. 2014, 51, 366–374. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tomar, S.; Sethi, R.; Sundar, G.; Quah, T.C.; Quah, B.L.; Lai, P.S. Mutation spectrum of RB1 mutations in retinoblastoma cases from Singapore with implications for genetic management and counselling. PLoS ONE 2017, 12, e0178776. [Google Scholar] [CrossRef] [Green Version]
- Chinnam, M.; Goodrich, D.W. RB1, development, and cancer. Curr. Top. Dev. Biol. 2011, 94, 129–169. [Google Scholar] [CrossRef] [Green Version]
- Kooi, I.E.; Mol, B.M.; Massink, M.P.; Ameziane, N.; Meijers-Heijboer, H.; Dommering, C.J.; van Mil, S.E.; de Vries, Y.; van der Hout, A.H.; Kaspers, G.J.; et al. Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes. Sci. Rep. 2016, 6, 25264. [Google Scholar] [CrossRef] [Green Version]
- Corson, T.W.; Gallie, B.L. One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma. Genes Chromosomes Cancer 2007, 46, 617–634. [Google Scholar] [CrossRef]
- Berry, J.L.; Xu, L.; Kooi, I.; Murphree, A.L.; Prabakar, R.K.; Reid, M.; Stachelek, K.; Le, B.H.A.; Welter, L.; Reiser, B.J.; et al. Genomic cfDNA Analysis of Aqueous Humor in Retinoblastoma Predicts Eye Salvage: The Surrogate Tumor Biopsy for Retinoblastoma. Mol. Cancer Res. 2018, 16, 1701–1712. [Google Scholar] [CrossRef] [Green Version]
- Yang, M.; Wei, W. Long non-coding RNAs in retinoblastoma. Pathol. Res. Pract. 2019, 215, 152435. [Google Scholar] [CrossRef]
- Brooks, B.P.; Macdonald, I.M.; Tumminia, S.J.; Smaoui, N.; Blain, D.; Nezhuvingal, A.A.; Sieving, P.A. Genomics in the era of molecular ophthalmology: Reflections on the National Ophthalmic Disease Genotyping Network (eyeGENE). Arch. Ophthalmol. 2008, 126, 424–425. [Google Scholar] [CrossRef] [Green Version]
- Goetz, K.E.; Reeves, M.J.; Tumminia, S.J.; Brooks, B.P. eyeGENE(R): A novel approach to combine clinical testing and researching genetic ocular disease. Curr. Opin. Ophthalmol. 2012, 23, 355–363. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Alapati, A.; Goetz, K.; Suk, J.; Navani, M.; Al-Tarouti, A.; Jayasundera, T.; Tumminia, S.J.; Lee, P.; Ayyagari, R. Molecular diagnostic testing by eyeGENE: Analysis of patients with hereditary retinal dystrophy phenotypes involving central vision loss. Investig. Ophthalmol. Vis. Sci. 2014, 55, 5510–5521. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Blain, D.; Goetz, K.E.; Ayyagari, R.; Tumminia, S.J. eyeGENE(R): A vision community resource facilitating patient care and paving the path for research through molecular diagnostic testing. Clin. Genet. 2013, 84, 190–197. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kooi, I.E.; Mol, B.M.; Moll, A.C.; van der Valk, P.; de Jong, M.C.; de Graaf, P.; van Mil, S.E.; Schouten-van Meeteren, A.Y.; Meijers-Heijboer, H.; Kaspers, G.L.; et al. Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression. EBioMedicine 2015, 2, 660–670. [Google Scholar] [CrossRef] [Green Version]
- Berry, J.L.; Xu, L.; Murphree, A.L.; Krishnan, S.; Stachelek, K.; Zolfaghari, E.; McGovern, K.; Lee, T.C.; Carlsson, A.; Kuhn, P.; et al. Potential of Aqueous Humor as a Surrogate Tumor Biopsy for Retinoblastoma. JAMA Ophthalmol. 2017, 135, 1221–1230. [Google Scholar] [CrossRef] [Green Version]
- Gerrish, A.; Stone, E.; Clokie, S.; Ainsworth, J.R.; Jenkinson, H.; McCalla, M.; Hitchcott, C.; Colmenero, I.; Allen, S.; Parulekar, M.; et al. Non-invasive diagnosis of retinoblastoma using cell-free DNA from aqueous humour. Br. J. Ophthalmol. 2019. [Google Scholar] [CrossRef] [Green Version]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Gudiseva, H.V.; Berry, J.L.; Polski, A.; Tummina, S.J.; O’Brien, J.M. Next-Generation Technologies and Strategies for the Management of Retinoblastoma. Genes 2019, 10, 1032. https://doi.org/10.3390/genes10121032
Gudiseva HV, Berry JL, Polski A, Tummina SJ, O’Brien JM. Next-Generation Technologies and Strategies for the Management of Retinoblastoma. Genes. 2019; 10(12):1032. https://doi.org/10.3390/genes10121032
Chicago/Turabian StyleGudiseva, Harini V., Jesse L. Berry, Ashley Polski, Santa J. Tummina, and Joan M. O’Brien. 2019. "Next-Generation Technologies and Strategies for the Management of Retinoblastoma" Genes 10, no. 12: 1032. https://doi.org/10.3390/genes10121032
APA StyleGudiseva, H. V., Berry, J. L., Polski, A., Tummina, S. J., & O’Brien, J. M. (2019). Next-Generation Technologies and Strategies for the Management of Retinoblastoma. Genes, 10(12), 1032. https://doi.org/10.3390/genes10121032